Botryoid Wilms Tumor with Left-Sided Inferior Vena Cava: A Case Report

Chi Y. · Li M. · Chen S. · Zhang W. · Liu P.

Author affiliations

Department of Urology, Beijing Children’s Hospital, National Center for Children’s Health, Capital Medical University, Beijing, China

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Abstract of Case Report

Received: July 23, 2022
Accepted: August 30, 2022
Published online: November 16, 2022

Number of Print Pages: 4
Number of Figures: 2
Number of Tables: 0

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Abstract

Wilms tumor (WT) is the second most common solid tumor in pediatric population. Botryoid WT is an uncommon growth pattern of WT, which is characterized by tumor extension into collecting system. A case of a 27-month-old boy with botryoid WT and left-sided inferior vena cava is reported in this article to emphasize the importance of preoperative imaging in preoperative planning.

© 2022 S. Karger AG, Basel

References Ritchey M, Daley S, Shamberger RC, Ehrlich P, Hamilton T, Haase G, et al. Ureteral extension in Wilms’ tumor: a report from the National Wilms’ Tumor Study Group (NWTSG). J Pediatr Surg. 2008;43(9):1625–9. Vujanić GM, Schiavo Lena M, Sebire NJ. Botryoid Wilms tumor: a non-existent “entity” causing diagnostic and staging difficulties. Virchows Arch. 2019;474(2):227–34. Sun J, Ye WJ, Zhao HT, Shi CR. Bilateral intrarenal pelvis Wilms’ tumor with fibroepithelial polyp. J Pediatr Surg. 2005;40(10):1670–2. Soccorso G, Sehuraman C, Al-Adnani M, Yeomanson D, Walker J. Ureteric extension of Wilms’ tumour: a case report. J Pediatr Urol. 2013;9(1):e3–5. Karnak İ, Haliloğlu M, Orhan D, Kutluk T. Wilms tumor extension into duplex ureter in a 10-year-old girl. J Pediatr Hematol Oncol. 2017;39(3):e140–2. Tunali N, Tuncer I, Zorludemir U, Zorludemir S, Tunali C. Botryoid nephroblastoma (Wilms’ tumor) in a hypoplastic kidney. Turk J Pediatr. 1987;29(1):45–9. Ang WC, Doyle T, Stringer MD. Left-sided and duplicate inferior vena cava: a case series and review. Clin Anat. 2013;26(8):990–1001. Qureshi SS, Bhagat M, Kazi M, Kembhavi SA, Yadav S, Parambil BC. Standardizing lymph nodal sampling for Wilms tumor: a feasibility study with outcomes. J Pediatr Surg. 2020;55(12):2668–75. Article / Publication Details

First-Page Preview

Abstract of Case Report

Received: July 23, 2022
Accepted: August 30, 2022
Published online: November 16, 2022

Number of Print Pages: 4
Number of Figures: 2
Number of Tables: 0

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

留言 (0)

沒有登入
gif